J. Uriach y Cia SA manufactures and markets pharmaceutical products. It offers consumer health products, including over-the-counter drugs, food supplements, personal health and wellbeing products, and nutricosmetic products. The company was founded by Juan Uriach Feliu in 1838 and is headquartered in Barcelona, Spain.

Part of Teva Pharmaceutical Industries Ltd., Pharmachemie BV (doing business as Teva Pharmachemie BV) is a company headquartered in Haarlem, the Netherlands, that produces pharmanceutical products.

Nippon Suisan produces and distributes seafood products. It offers fresh and frozen fish and other fish products including fish oil. It is a subsidiary of Nippon Suisan Kaisha Ltd. The company is headquartered in Tokyo, Japan.

Liaoning Kailaiying Pharmaceutical Chemical Co., Ltd., established on 2013-12-02, Business scope includes licensed projects:Hazardous Chemical Production,pharmaceutical production,Pharmaceutical commissioned production,Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Chemical product production(No licensed chemical products),Chemical product sales(No licensed chemical products),Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals),Specialty Chemicals Sales(Free of Hazardous Chemicals),Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals),Medical Research and Experimental Development,R&D of industrial enzyme preparations,Fermentation process optimization technology research and development,Pharmaceutical special equipment manufacturing,Pharmaceutical special equipment sales,Mechanical Parts,Parts sales,Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Special equipment rental,General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval),Non-residential real estate leases(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shandong Jincheng Kerui Chemical Co. Ltd., a subsidiary of Shandong Jincheng Pharmaceutical Group Co., Ltd., is a company headquartered in Zibo, China, that manufactures chemical products. Xue Bo Zhang is the current CEO of the firm.

Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France.

Shenzhen Lanxin Technology Co., Ltd., established on 2016-11-21, Business scope includes general business items:Instrument technology development,technical consulting,Technical Services;Drug development and technical consultation,technology transfer,Technical Services;Domestic Trade;Operating import and export business.(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating),The licensing program is:Production of raw materials

Ali Biological New Materials (Changzhou) Co., Ltd., established on 2017-08-28, The business scope includes biomaterial hydrogels for three-dimensional cell culture,Hydrogel Media Diagnostic Kit,Technology research and development of hydrogel facial mask cosmetics,technical consulting,Technical Services;Sales of hydrogels;Chemical intermediate reagent,Research and development and technical consultation of bioinhibitor reagents,Technical Services;Chemical products and raw materials(In addition to dangerous goods)promotion of;Self-operated and agent import and export business of various commodities and technologies,Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export.(Except those involving national special management measures,Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shaanxi Licai Pharmaceutical Co., Ltd., established on 2003-12-29, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;Sales of Class II Medical Devices;food business(Only sell prepackaged food)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Pharmaceutical commissioned production;Drug retail;Drug Wholesale;Health Supplies(non food)Sales;food business(sell bulk food)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Fujitsu Semiconductor Ltd. provides electronic devices. The company produces a variety of semiconductors for automotive, consumer, industrial, networking, and wireless applications. The company was established in Tokyo, Japan.

Part of Fresenius Medical Care AG & Co. KGaA, Fresenius Kabi iPSUM SRL is a company headquartered in Cernusco Sul Naviglio, Italy. The firm manufactures and supplies pharmaceutical ingredients. It was founded in 1975.

Kanghua (Shanghai) New Drug Research and Development Co., Ltd., established on 2004-07-09, Business scope includes research and development of new drugs,Production of Unnatural Amino Acids,Fine chemicals such as natural amino acid peptides,Sell ​​self-produced products,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shanghai Changsen Pharmaceutical Co., Ltd., established on 2012-05-23, Business scope includes licensed projects:Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:medical products,biomedical technology(remove human stem cells,Development and application of genetic diagnosis and treatment technology),Technical services in the field of medical device technology,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Sales of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Chengdu Daoheer Medical Technology Co., Ltd., established on 2017-03-30, Business scope includes medical technology research and development;Research and development of chemical products and biotechnology,technology transfer,Technical Advisory Services;Sales:Chemical Products(Free of Hazardous Chemicals),chemical reagent(Free of Hazardous Chemicals);Import and export of goods and technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Nippon Telegraph & Telephone Corp. operates as a holding company which engages in the provision of telecommunication services. It operates through the following business divisions: Regional Communications, Long-Distance and International Communications, Mobile Communications, Data Communications, and Others. The Regional Communications division offers domestic intra-prefectural communication services such as fixed voice-related, Internet protocol (IP), and packet communications services; and sells telecommunications equipment. The Long Distance and International Communications division deals with the domestic intra-prefectural and international communications, and system integration services. The Mobile Communications division provides the mobile voice-related, IP, and packet communications services. The Data Communications division covers the system integration and network system services. The Other division engages in the real estate, finance, engineering, system integration and data processing services, and development of technologies and shared operations. The company was founded on August 1, 1952 and is headquartered in Tokyo, Japan.

The American Can Company was a manufacturer of tin cans. It was a member of the Tin Can Trust, that controlled a "large percentage of business in the United States in tin cans, containers, and packages of tin." American Can Company ranked 97th among United States corporations in the value of World War II military production contracts. It was formerly a member of the Dow Jones Industrial Average from 1959–1991, though after 1987 it had renamed itself Primerica, a financial conglomerate which had divested itself of its packaging arm in 1986.

Chemetall is a global technology and innovation leader in the metals surface treatment market, and is headquartered in Frankfurt, Germany. It has approximately 2,500 employees globally, and operates 21 production sites in more than 20 countries, as well as 10 R&D locations and 24 sales offices. For the full calendar year of 2015, its sales were $845 million.

Henan Yuanbo New Materials Co., Ltd., established on 2017-06-23, Business scope includes general items:Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals);Chemical product production(No licensed chemical products);Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Manufacturing of daily chemical products;synthetic material manufacturing(Free of Hazardous Chemicals);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;New material technology research and development;Biochemical product technology research and development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:second,Phosphorus contained in Class III monitored chemicals and Class IV monitored chemicals,sulfur,Production of Fluorine Specific Organic Chemicals;Production of new chemical substances(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)